Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

7,232 total articles

MSDL: Upgrade to Buy — A Contrarian Play on a 0.78x NAV Disconnect

MSDL: Upgrade to Buy — A Contrarian Play on a 0.78x NAV Disconnect

Morgan Stanley Direct Lending Fund (MSDL) trades at roughly 0.78x NAV and yields north of 13%. The fund's senior-secured, middle-market loan book and quarterly $0.45 distribution create an attractive carry-recapture trade if credit trends remain stable. We upgrade to Buy with a clear trade plan: entry $15.00, stop $13.50, target $19.40 over a long-…

CuriosityStream: High Yield With a Defensive Cash Flow Moat

CuriosityStream: High Yield With a Defensive Cash Flow Moat

CuriosityStream (CURI) trades at roughly $2.46, spits off meaningful free cash flow and is currently paying a quarterly dividend that pushes headline yield into the low double digits. For investors willing to take on operational execution risk in small-cap media, a disciplined long entry around $2.46 with a stop at $2.20 and a $3.80 target offers a…

Korn Ferry: Ride the Labor-Market-Driven Upswing into Q4

Korn Ferry: Ride the Labor-Market-Driven Upswing into Q4

Korn Ferry is positioned to benefit from productivity investments and an improving labor market. Recent results show fee revenue growth, strong cash on the balance sheet and a reasonable valuation. This trade idea proposes a mid-term long with clearly defined entry, stop and target anchored to technicals and fundamental catalysts.

Buy the Dip in Alphabet: Weather the Jump-Slump, Hold for Rebound

Buy the Dip in Alphabet: Weather the Jump-Slump, Hold for Rebound

Alphabet (GOOGL) has pulled back after a brief 'jump' in sentiment; this trade idea recommends entering at $160.00 with a stop at $145.00 and a target of $205.00 on a mid-term, 45 trading day horizon. The thesis: core ad revenue and accelerating AI/cloud monetization provide a durable earnings floor while near-term multiples can expand on positive …

RideNow Group: Buy the Pullback — A Practical Mid-Term Trade

RideNow Group: Buy the Pullback — A Practical Mid-Term Trade

RideNow Group (RDNW) looks appealing after a pullback from its May highs. The company trades at roughly $254.7M market cap with free cash flow of $14M and an EV/sales of 0.63. Technicals show oversold momentum while short interest and active short-volume create a setup for a mid-term mean-reversion into the $8s. This trade lays out a clear entry at…

Hubbell: Buy the Grid Upgrade, Ride the M&A-Driven Re-rating

Hubbell: Buy the Grid Upgrade, Ride the M&A-Driven Re-rating

Hubbell (HUBB) is a high-quality electrical-products compounder trading at a premium multiple but backed by strong cash flow, robust ROE, and acquisitive growth that plugs directly into the electrification and smart-building upcycle. Enter around $518.00 with a $565.50 target and $485.00 stop; the setup balances catalyst-driven upside with defined …

EPAM: Cheap Access to a Hard-to-Replicate AI Engineering Moat

EPAM: Cheap Access to a Hard-to-Replicate AI Engineering Moat

EPAM trades near $77 after a brutal re-rating tied to a large customer ramp-down disclosure and class-action noise. Fundamentals still show healthy cash generation ($543.6M FCF), low leverage (debt/equity 0.05) and an attractive valuation (EV/EBITDA ~4.7). This trade idea argues the market has overshot on headline risk and that a measured long with…

Scorpio Tankers: Buy for Yield + Buybacks as TCEs Stay Elevated

Scorpio Tankers: Buy for Yield + Buybacks as TCEs Stay Elevated

Scorpio Tankers (STNG) looks buyable here. Elevated Time Charter Equivalent (TCE) rates, a string of asset sales and long-term charters, and recent convertible-note issuances tied to targeted share repurchases give the company both cash and a visible path to accelerate capital returns. The stock trades at a modest P/E of 7.5 and a PB of ~1.22 with …

Label Path and Clinical Momentum: A Tactical Long on MoonLake (MLTX)

Label Path and Clinical Momentum: A Tactical Long on MoonLake (MLTX)

MoonLake Immunotherapeutics has materially de‑risked its lead program after FDA confirmations and positive Week 40 Phase 3 data. With cash runway into late 2027 and an upcoming BLA submission in H2 2026, the stock looks positioned for a re-rating if 52‑week data and regulatory engagement continue to favor approval. We outline a long trade with entr…

Novo Nordisk: Buying the Panic - A Contrarian Trade After the Big Reset

Novo Nordisk: Buying the Panic - A Contrarian Trade After the Big Reset

Novo Nordisk ($NVO) has been hammered to the mid-$40s after a year of pricing and competitive concerns. The selloff has pushed the stock to a single-digit P/E near 10x and a market cap of about $204 billion. Management is buying shares back and core obesity/diabetes demand remains sizable. This trade idea proposes a buy at $46.50, with a $42.00 sto…

Whitbread: Estate Disposals Can Fund a 15% Annualized Return

Whitbread: Estate Disposals Can Fund a 15% Annualized Return

Whitbread will likely unlock material cash by selectively disposing of parts of its estate. If management executes disciplined estate recycling, proceeds can fund buybacks, debt paydown and reinvestment, supporting a mid-single-digit multiple re-rate. We initiate a tactical long aiming for ~15% annualized return, with defined entry, stop and target…